by Harry Alexander | Apr 26, 2023 | Innovation Prize
Bristol, 27 April 2023 – QantX is proud to announce three new recipients of the 2023 Blavatnik Prize for Innovation. This prestigious £1m prize fund provides non-dilutive prizes to unlock the commercialisation of innovations across sustainability, healthcare, and AI....
by Harry Alexander | Feb 16, 2023 | Healthcare, Portfolio
Headline: Rapid diagnostic technology spun out from the University of Southampton can identify antibiotic resistance 10x faster than current gold standards Working closely with UKHSA at the world-leading microbiology labs in Porton Down to demonstrate clinical...
by Harry Alexander | Jan 9, 2023 | Healthcare
QantX is delighted to announce its investment in the team at Molendotech as they seek funding to help them scale and deliver their solution for rapid on-site pathogen detection. Every day, 2 million tonnes of sewage and other effluents drain into the World’s waters,...
by Harry Alexander | Nov 8, 2022 | Healthcare, Innovation Prize
Existing clinical pathways for eyecare are overwhelmed with the significant backlog of patients in secondary care. Before the C-19 pandemic, four million patients in the UK were referred to hospitals but had not been treated within 18 weeks. Further, a pause on...
by Harry Alexander | Oct 31, 2022 | Innovation, Innovation Prize
QantX has awarded Matthew Bone, CEO of Molydyn, a £25,000 Blavatnik Prize for Innovation to support commercial trials and further development of his newly released Atlas platform. Computational tools have shown extreme benefits for biological sciences and drug...
